Accessibility Menu
Precision Peptide logo

Precision Peptide(OTC) PNGAF

Market Cap$9.13MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-86%
5 YearN/A
1 Year+39%
1 Month-3%
$0.35
+10.34%
+0.03Today
Precision Peptide last closing stock price
MetricPriceDate
Last closeUSD 0.322026-08-03
Precision Peptide stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-5.97%USD 0.342026-07-27
1 month-3.34%USD 0.332026-07-02
3 month-12.83%USD 0.372026-05-05
Year to date+55.06%USD 0.212025-12-31
1 year+38.99%USD 0.232025-07-09
3 year-46.65%USD 0.602023-07-31
Since inception-86.45%USD 2.362022-08-25

Precision Peptide Financials at a Glance

Market Cap

$9.13MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$109.17K

Net Income (TTM)

-CA$5.98M

EPS (TTM)

-$0.15

P/E Ratio

-2.15

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.35

Volume

36,552

Open

$0.33

Previous Close

$0.35

Daily Range

$0.33 - $0.36

52-Week Range

$0.01 - $0.50

Estimated Earnings Date

N/A

PNGAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Precision Peptide

Pangea Wellness Inc. is a company focused on creating and selling plant-based food alternatives in both Canadian and U.S. markets. The product line includes plant-based patties, Old Fashioned Ghee, and vegan Chickn' bites, catering to the growing demand for healthier food options.

Products and Services
  • Plant-based patties designed for diverse culinary applications
  • Old Fashioned Ghee, a unique butter alternative
  • Vegan Chickn' bites, a plant-based nugget option
Growth Outlook
  • Increasing consumer demand for plant-based foods supports market expansion
  • Strategic partnerships with retailers enhance product distribution
  • Focus on e-commerce channels drives sales growth potential
Financial Highlights
  • Recent quarterly revenue of CAD 16,402 reflects ongoing market challenges
  • Trailing twelve months (TTM) revenue of CAD 64,258 indicates growth opportunities
  • Current ratio of 3.32 suggests strong liquidity position
Pangea Wellness Inc. operates in the packaged foods industry, emphasizing plant-based alternatives that align with current health trends. The company has established a diverse product range, appealing to a growing consumer base seeking healthier dietary options. Despite facing challenges reflected in recent financial performance, the company maintains a strong liquidity position, as indicated by a current ratio of 3.32. This suggests that Pangea Wellness Inc. is well-positioned to navigate short-term financial obligations while pursuing growth opportunities in the expanding plant-based food market. The strategic focus on e-commerce and partnerships with retailers further enhances the potential for revenue growth, making it an intriguing option for investors interested in the health food sector.
AI Generated • Jul 14, 2026

Industry

Food Products

CEO

Pratapvir Sandhu

Headquarters

Surrey, BC V3W 0H7, CA

PNGAF Financials

Key Financial Metrics (TTM)

Gross Margin

-48.83%

Operating Margin

-4131.04%

Net Income Margin

-8804.16%

Return on Equity

-162.93%

Return on Capital

-242.25%

Return on Assets

-328.89%

Earnings Yield

-46.51%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.13MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

28.52M

Volume

36.55K

Avg. Volume

62.13K

Financials (TTM)

Gross Profit

-CA$764.33K

Operating Income

-CA$3.71M

EBITDA

-CA$3.65M

Operating Cash Flow

-CA$2.65M

Capital Expenditure

-CA$5.46

Free Cash Flow

-CA$2.65M

Cash & ST Invst.

CA$772.97K

Total Debt

CA$0.00

Precision Peptide Performance Analysis

Precision Peptide annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-10-31CAD 451,098728.8%
20232023-10-31CAD 211,736-53.1%
20242024-10-31CAD 8,963-95.8%
20252025-10-31CAD 35,505296.1%
Precision Peptide sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-07-31N/A
Q42025-10-31640.3%
Q12026-01-31-1.7%
Q22026-04-30-61.9%
Precision Peptide annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-10-31CAD -0.19535.1%
20232023-10-31CAD -0.2212.9%
20242024-10-31CAD -0.11-47.6%
20252025-10-31CAD -0.1531.7%
Precision Peptide sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-07-31-17.0%
Q42025-10-31-412.8%
Q12026-01-3158.9%
Q22026-04-3071.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$16.40K

N/A

Gross Profit

-CA$276.00

N/A

Gross Margin

-1.68%

N/A

Market Cap

$9.13MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$4.56M

N/A

Employees

2

N/A

Net Income

-CA$510.62K

-61.7%

EBITDA

-CA$479.23K

-79.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$772.97K

+433.7%

Total Debt

CA$0.00

-100.0%

Accounts Receivable

CA$82.05K

+87.8%

Inventory

CA$48.85K

N/A

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$0.00

-100.0%

Return on Assets

-3.29%

N/A

Return on Invested Capital

-2.21%

N/A

Free Cash Flow

-CA$862.98K

-53.7%

Operating Cash Flow

-CA$862.99K

-53.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AIXNAiXin Life International, Inc.
$0.26+0.00%
GLUCGlucose Health, Inc.
$0.35+16.67%
TOFBTofutti Brands Inc.
$0.65+0.00%
RELVReliv' International, Inc.
$1.83+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Questions About PNGAF

What is the current price of Precision Peptide?

Precision Peptide is trading at $0.35 per share.

What is the 52-week range for Precision Peptide?

Over the past 52 weeks, Precision Peptide has traded between $0.01 and $0.50.

How much debt does Precision Peptide have?

As of the most recent reporting period, Precision Peptide reported total debt of CA$0.00.

How much cash does Precision Peptide have on hand?

Precision Peptide reported CA$568.09K in cash and cash equivalents in its most recent financial results.

What is Precision Peptide’s dividend yield?

Precision Peptide does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.